Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
HERMES PHARMA is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Austria
Founded:2018
Employees:2,757
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
14
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval P3VT0J
PMDA · #APR-235OOMKT · 2022-06-01
Drug Approval 67WMF2
Health Canada · #APR-Y1LVCGBR · 2022-01-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-XDWT7I12
Issued: 2020-08-19
Expires: 2025-03-24
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-U4EAPE4X
Issued: 2020-10-13
Expires: 2025-05-25
Loading CDMO intelligence...
Key facts about HERMES PHARMA
- HERMES PHARMA is headquartered in Austria.
- HERMES PHARMA was founded in 2018.
- HERMES PHARMA has 2,757 employees.
- HERMES PHARMA's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like HERMES PHARMA
Directory pages this company appears in, each with the full list of matching manufacturers.